All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional.

The ALL Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Why should CAR T-cell therapy be used earlier in ALL?

During the Acute Leukemia Forum (ALF) 2021, the ALL Hub spoke to Stephan A. Grupp, Children’s Hospital of Philadelphia, Philadelphia, US. We asked, Why should CAR T-cell therapy be used earlier in ALL?

Why should CAR T-cell therapy be used earlier in ALL?

In this video, Grupp outlines what groups of patients with ALL could benefit from earlier treatment with CAR T-cell infusions.

 

Share:
More about...